654
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

mTOR inhibitor-related pulmonary toxicity; incidence even higher

&
Page 1234 | Received 19 Dec 2012, Accepted 19 Jan 2013, Published online: 14 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nisha A Mohindra, Francis J Giles & Leonidas C Platanias. (2014) Use of mTOR inhibitors in the treatment of malignancies. Expert Opinion on Pharmacotherapy 15:7, pages 979-990.
Read now

Articles from other publishers (3)

Georg Maschmeyer, Julien De Greef, Sibylle C. Mellinghoff, Annamaria Nosari, Anne Thiebaut-Bertrand, Anne Bergeron, Tomas Franquet, Nicole M. A. Blijlevens & Johan A. Maertens. (2019) Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL). Leukemia 33:4, pages 844-862.
Crossref
Mizuki Nishino, Erica N. Boswell, Hiroto Hatabu, Irene M. Ghobrial & Nikhil H. Ramaiya. (2015) Drug‐Related Pneumonitis During Mammalian Target of Rapamycin Inhibitor Therapy: Radiographic Pattern‐Based Approach in Waldenström Macroglobulinemia as a Paradigm. The Oncologist 20:9, pages 1077-1083.
Crossref
David H. Harter, Luigi BassaniShaun D. RodgersJonathan RothOrrin Devinsky, Chad Carlson, Jeffery H. Wisoff & Howard L. Weiner. (2014) A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex. Journal of Neurosurgery: Pediatrics 13:1, pages 21-28.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.